Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT02533258
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed as advanced RCC by histology or cytology
* Patients using axitinib as therapy after failure of sunitinib or cytokine
* Patients received axitinib treatment and follow up in the health care center participating present registry
* Patients agree to participate and signed inform consent or IRB waiving of signed informed consent document is available
Exclusion Criteria:
* Patients with first dose of axitinib earlier than 7th May 2013
* Patients with first dose of axitinib later than 30th June 2015.
* Patients participating in clinical research involving axitinib
* Patients with hypersensitivity to axitinib or to any other component of axitinib
* Patients under 18-year of age
* Pregnant women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02533258
Study Brief:
Protocol Section:
NCT02533258